Login
Companies $PAYS
$9.52 -$0.02 (0.21%) After hours
Paysign, Inc. logo

Paysign, Inc.

paysign.com

What Do They Do?

Provides prepaid card products and processing services for corporate, consumer and government entities, plus software for blood and plasma collection organizations.

Who Are Their Customers?

Corporate and government organizations use payment programs, while pharmaceutical companies sponsor patient affordability offerings and blood and plasma collection organizations are software targets. Paysign markets payment solutions through its own sales team; end users receive cards through issuing-bank partners.

Do Revenues Turn Into Profits?

Yes. It kept 9 cents of every revenue dollar as net income in FY2025 and turned 62 cents into free cash flow.

Operating income, FY2025
9% of revenue
▲ +621% vs FY2024 ($1M, 2%)
Net income, FY2025
9% of revenue
▲ +98% vs FY2024 ($3.8M, 7%)
Free cash flow, FY2025
62% of revenue
▲ +128% vs FY2024 ($22.5M, 39%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +43%
vs $21.6M in Q3 FY2025
Net income
▲ +204%
vs $2.2M in Q3 FY2025
  • Nov 9, 2026 Raises 2026 earnings guidance; plasma customer plans to move 113 centers The centers generated $11.3 million in trailing 12-month revenue; Paysign estimated a $1.5 million fourth-quarter revenue impact.

Life-science software Paysign has added a life-science software business for blood and plasma collection organizations through its Gamma Innovation acquisition, alongside the prepaid-card operation described in the older report.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support